0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-29D11405
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2022
BUY CHAPTERS

Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2025

Code: QYRE-Auto-29D11405
Report
March 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%.

Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market

Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market

The global market for Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 139%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient.
The Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Report

Report Metric Details
Report Name Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market
Accounted market size in 2022 $ 261 billion
Base Year 2022
by Type
  • Purity ≥98%
  • Purity <98%
by Application
  • Oral Drug
  • External Drug
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Nissan Chemical, HIKAL Ltd., HuBei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu Group, Zhejiang Gihi Chemicals, Taizhou Crene Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market report?

Ans: The main players in the Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market are Nissan Chemical, HIKAL Ltd., HuBei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu Group, Zhejiang Gihi Chemicals, Taizhou Crene Biotechnology

What are the Application segmentation covered in the Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market report?

Ans: The Applications covered in the Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market report are Oral Drug, External Drug

What are the Type segmentation covered in the Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market report?

Ans: The Types covered in the Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market report are Purity ≥98%, Purity <98%

1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Overview
1.1 Product Definition
1.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient by Type
1.2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity ≥98%
1.2.3 Purity <98%
1.3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient by Application
1.3.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Oral Drug
1.3.3 External Drug
1.4 Global Market Growth Prospects
1.4.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Estimates and Forecasts (2020-2031)
1.4.4 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share by Manufacturers (2020-2025)
2.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, Industry Ranking, 2023 VS 2024
2.4 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, Product Offered and Application
2.8 Global Key Manufacturers of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, Date of Enter into This Industry
2.9 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Competitive Situation and Trends
2.9.1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Concentration Rate
2.9.2 Global 5 and 10 Largest Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Region
3.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Region (2020-2031)
3.2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient by Region (2026-2031)
3.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Volume by Region (2020-2031)
3.4.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient by Region (2026-2031)
3.5 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Price Analysis by Region (2020-2025)
3.6 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production and Value, Year-over-Year Growth
3.6.1 North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Estimates and Forecasts (2020-2031)
4 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Region
4.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Region (2020-2031)
4.2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Region (2020-2025)
4.2.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Type (2020-2031)
5.1.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Type (2020-2025)
5.1.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Type (2026-2031)
5.1.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share by Type (2020-2031)
5.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Type (2020-2031)
5.2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Type (2020-2025)
5.2.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Type (2026-2031)
5.2.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Market Share by Type (2020-2031)
5.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price by Type (2020-2031)
6 Segment by Application
6.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Application (2020-2031)
6.1.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Application (2020-2025)
6.1.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Application (2026-2031)
6.1.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share by Application (2020-2031)
6.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Application (2020-2031)
6.2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Application (2020-2025)
6.2.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Application (2026-2031)
6.2.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Market Share by Application (2020-2031)
6.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Nissan Chemical
7.1.1 Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Company Information
7.1.2 Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Portfolio
7.1.3 Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Nissan Chemical Main Business and Markets Served
7.1.5 Nissan Chemical Recent Developments/Updates
7.2 HIKAL Ltd.
7.2.1 HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Company Information
7.2.2 HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Portfolio
7.2.3 HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production, Value, Price and Gross Margin (2020-2025)
7.2.4 HIKAL Ltd. Main Business and Markets Served
7.2.5 HIKAL Ltd. Recent Developments/Updates
7.3 HuBei Masteam Bio-tech
7.3.1 HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Company Information
7.3.2 HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Portfolio
7.3.3 HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production, Value, Price and Gross Margin (2020-2025)
7.3.4 HuBei Masteam Bio-tech Main Business and Markets Served
7.3.5 HuBei Masteam Bio-tech Recent Developments/Updates
7.4 Jiangsu Rivocean
7.4.1 Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Company Information
7.4.2 Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Portfolio
7.4.3 Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Jiangsu Rivocean Main Business and Markets Served
7.4.5 Jiangsu Rivocean Recent Developments/Updates
7.5 Shaanxi Dideu Group
7.5.1 Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Company Information
7.5.2 Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Portfolio
7.5.3 Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Shaanxi Dideu Group Main Business and Markets Served
7.5.5 Shaanxi Dideu Group Recent Developments/Updates
7.6 Zhejiang Gihi Chemicals
7.6.1 Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Company Information
7.6.2 Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Portfolio
7.6.3 Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Zhejiang Gihi Chemicals Main Business and Markets Served
7.6.5 Zhejiang Gihi Chemicals Recent Developments/Updates
7.7 Taizhou Crene Biotechnology
7.7.1 Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Company Information
7.7.2 Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Portfolio
7.7.3 Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Taizhou Crene Biotechnology Main Business and Markets Served
7.7.5 Taizhou Crene Biotechnology Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Industry Chain Analysis
8.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Mode & Process Analysis
8.4 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Marketing
8.4.1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Channels
8.4.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Distributors
8.5 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Customer Analysis
9 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Dynamics
9.1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Industry Trends
9.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Drivers
9.3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Challenges
9.4 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient as of 2024)
 Table 10. Global Market Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Average Price by Manufacturers (US$/Ton) & (2020-2025)
 Table 11. Global Key Manufacturers of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, Product Offered and Application
 Table 13. Global Key Manufacturers of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, Date of Enter into This Industry
 Table 14. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Market Share by Region (2020-2025)
 Table 19. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production (Tons) by Region (2020-2025)
 Table 23. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share by Region (2020-2025)
 Table 24. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Average Price (US$/Ton) by Region (2020-2025)
 Table 27. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Average Price (US$/Ton) by Region (2026-2031)
 Table 28. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Market Share by Region (2020-2025)
 Table 31. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production (Tons) by Type (2020-2025)
 Table 46. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production (Tons) by Type (2026-2031)
 Table 47. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share by Type (2020-2025)
 Table 48. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share by Type (2026-2031)
 Table 49. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Market Share by Type (2020-2025)
 Table 52. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Market Share by Type (2026-2031)
 Table 53. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (US$/Ton) by Type (2020-2025)
 Table 54. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (US$/Ton) by Type (2026-2031)
 Table 55. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production (Tons) by Application (2020-2025)
 Table 56. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production (Tons) by Application (2026-2031)
 Table 57. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share by Application (2020-2025)
 Table 58. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share by Application (2026-2031)
 Table 59. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Market Share by Application (2020-2025)
 Table 62. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Market Share by Application (2026-2031)
 Table 63. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (US$/Ton) by Application (2020-2025)
 Table 64. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (US$/Ton) by Application (2026-2031)
 Table 65. Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Company Information
 Table 66. Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Specification and Application
 Table 67. Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 68. Nissan Chemical Main Business and Markets Served
 Table 69. Nissan Chemical Recent Developments/Updates
 Table 70. HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Company Information
 Table 71. HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Specification and Application
 Table 72. HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. HIKAL Ltd. Main Business and Markets Served
 Table 74. HIKAL Ltd. Recent Developments/Updates
 Table 75. HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Company Information
 Table 76. HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Specification and Application
 Table 77. HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. HuBei Masteam Bio-tech Main Business and Markets Served
 Table 79. HuBei Masteam Bio-tech Recent Developments/Updates
 Table 80. Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Company Information
 Table 81. Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Specification and Application
 Table 82. Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Jiangsu Rivocean Main Business and Markets Served
 Table 84. Jiangsu Rivocean Recent Developments/Updates
 Table 85. Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Company Information
 Table 86. Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Specification and Application
 Table 87. Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Shaanxi Dideu Group Main Business and Markets Served
 Table 89. Shaanxi Dideu Group Recent Developments/Updates
 Table 90. Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Company Information
 Table 91. Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Specification and Application
 Table 92. Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Zhejiang Gihi Chemicals Main Business and Markets Served
 Table 94. Zhejiang Gihi Chemicals Recent Developments/Updates
 Table 95. Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Company Information
 Table 96. Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Specification and Application
 Table 97. Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Taizhou Crene Biotechnology Main Business and Markets Served
 Table 99. Taizhou Crene Biotechnology Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Distributors List
 Table 103. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Customers List
 Table 104. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Trends
 Table 105. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Drivers
 Table 106. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Challenges
 Table 107. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient
 Figure 2. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Share by Type: 2024 VS 2031
 Figure 4. Purity ≥98% Product Picture
 Figure 5. Purity <98% Product Picture
 Figure 6. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Share by Application: 2024 VS 2031
 Figure 8. Oral Drug
 Figure 9. External Drug
 Figure 10. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value (US$ Million) & (2020-2031)
 Figure 12. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity (Tons) & (2020-2031)
 Figure 13. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production (Tons) & (2020-2031)
 Figure 14. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Average Price (US$/Ton) & (2020-2031)
 Figure 15. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Report Years Considered
 Figure 16. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Share by Manufacturers in 2024
 Figure 17. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Share by Manufacturers (2024)
 Figure 18. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. The Global 5 and 10 Largest Players: Market Share by Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue in 2024
 Figure 20. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 21. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 22. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 23. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 25. Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. China Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Japan Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 29. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 30. North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 31. North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Market Share by Country (2020-2031)
 Figure 32. U.S. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 33. Canada Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 34. Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Market Share by Country (2020-2031)
 Figure 36. Germany Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 37. France Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 38. U.K. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. Italy Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. Russia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. Asia Pacific Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. Asia Pacific Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Market Share by Region (2020-2031)
 Figure 43. China Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Japan Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. South Korea Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. China Taiwan Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. Southeast Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. India Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. Latin America, Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. Latin America, Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption Market Share by Country (2020-2031)
 Figure 51. Mexico Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. Brazil Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. Turkey Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. GCC Countries Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. Global Production Market Share of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient by Type (2020-2031)
 Figure 56. Global Production Value Market Share of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient by Type (2020-2031)
 Figure 57. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (US$/Ton) by Type (2020-2031)
 Figure 58. Global Production Market Share of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient by Application (2020-2031)
 Figure 59. Global Production Value Market Share of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient by Application (2020-2031)
 Figure 60. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (US$/Ton) by Application (2020-2031)
 Figure 61. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS